Standard BioTools Revenue 2010-2025 | LAB
Standard BioTools revenue from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Standard BioTools Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $174 |
| 2023 | $106 |
| 2022 | $98 |
| 2021 | $131 |
| 2020 | $138 |
| 2019 | $117 |
| 2018 | $113 |
| 2017 | $102 |
| 2016 | $104 |
| 2015 | $115 |
| 2014 | $116 |
| 2013 | $71 |
| 2012 | $52 |
| 2011 | $43 |
| 2010 | $34 |
| 2009 | $25 |
| Standard BioTools Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-06-30 | $22 |
| 2025-03-31 | $41 |
| 2024-12-31 | $61 |
| 2024-09-30 | $45 |
| 2024-06-30 | $22 |
| 2024-03-31 | $46 |
| 2023-12-31 | $28 |
| 2023-09-30 | $25 |
| 2023-06-30 | $28 |
| 2023-03-31 | $25 |
| 2022-12-31 | $27 |
| 2022-09-30 | $26 |
| 2022-06-30 | $19 |
| 2022-03-31 | $27 |
| 2021-12-31 | $38 |
| 2021-09-30 | $29 |
| 2021-06-30 | $31 |
| 2021-03-31 | $33 |
| 2020-12-31 | $45 |
| 2020-09-30 | $40 |
| 2020-06-30 | $26 |
| 2020-03-31 | $28 |
| 2019-12-31 | $32 |
| 2019-09-30 | $26 |
| 2019-06-30 | $28 |
| 2019-03-31 | $30 |
| 2018-12-31 | $32 |
| 2018-09-30 | $29 |
| 2018-06-30 | $26 |
| 2018-03-31 | $25 |
| 2017-12-31 | $28 |
| 2017-09-30 | $25 |
| 2017-06-30 | $24 |
| 2017-03-31 | $26 |
| 2016-12-31 | $25 |
| 2016-09-30 | $22 |
| 2016-06-30 | $28 |
| 2016-03-31 | $29 |
| 2015-12-31 | $31 |
| 2015-09-30 | $29 |
| 2015-06-30 | $29 |
| 2015-03-31 | $27 |
| 2014-12-31 | $33 |
| 2014-09-30 | $30 |
| 2014-06-30 | $28 |
| 2014-03-31 | $26 |
| 2013-12-31 | $21 |
| 2013-09-30 | $18 |
| 2013-06-30 | $17 |
| 2013-03-31 | $15 |
| 2012-12-31 | $16 |
| 2012-09-30 | $13 |
| 2012-06-30 | $13 |
| 2012-03-31 | $11 |
| 2011-12-31 | $13 |
| 2011-09-30 | $11 |
| 2011-06-30 | $11 |
| 2011-03-31 | $9 |
| 2010-12-31 | $10 |
| 2010-09-30 | $8 |
| 2010-06-30 | $8 |
| 2010-03-31 | $7 |
| 2009-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.493B | $0.174B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $44.502B | 54.47 |
| Doximity (DOCS) | United States | $12.809B | 56.99 |
| Tempus AI (TEM) | United States | $12.797B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $9.972B | 81.70 |
| IRhythm Technologies (IRTC) | United States | $5.509B | 0.00 |
| Hinge Health (HNGE) | United States | $4.528B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.705B | 39.76 |
| Privia Health (PRVA) | United States | $2.677B | 198.27 |
| Heartflow (HTFL) | $2.609B | 0.00 | |
| Phreesia (PHR) | United States | $1.937B | 0.00 |
| 10x Genomics (TXG) | United States | $1.778B | 0.00 |
| Enovis (ENOV) | United States | $1.749B | 9.24 |
| Omnicell (OMCL) | United States | $1.529B | 29.45 |
| Schrodinger (SDGR) | United States | $1.454B | 0.00 |
| Azenta (AZTA) | United States | $1.372B | 59.84 |
| Clover Health Investments (CLOV) | United States | $1.348B | 0.00 |
| Claritev (CTEV) | United States | $1.174B | 0.00 |
| Evolent Health (EVH) | United States | $1.133B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.674B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.550B | 0.00 |
| Veradigm (MDRX) | United States | $0.534B | 0.00 |
| Talkspace (TALK) | United States | $0.445B | 133.00 |
| Butterfly Network (BFLY) | United States | $0.410B | 0.00 |
| Carlsmed (CARL) | United States | $0.363B | 0.00 |
| TruBridge (TBRG) | United States | $0.300B | 52.60 |
| Health Catalyst (HCAT) | United States | $0.257B | 0.00 |
| Outset Medical (OM) | United States | $0.247B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.224B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.214B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| CapsoVision (CV) | United States | $0.184B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.164B | 0.00 |
| CareCloud (CCLD) | United States | $0.160B | 7.27 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.115B | 0.00 |
| American Well (AMWL) | United States | $0.113B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.082B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.072B | 0.00 |
| Pulmonx (LUNG) | United States | $0.072B | 0.00 |
| 111 (YI) | China | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| HeartBeam (BEAT) | United States | $0.044B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Precipio (PRPO) | United States | $0.025B | 0.00 |
| PROFUSA (PFSA) | United States | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.014B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |